Startups around the world are engaging in clinical trials in a sector that could change lives – and be worth more than £15bn by the 2030s
Oran Knowlson, a British teenager with a severe type of epilepsy called Lennox-Gastaut syndrome, became the first person in the world to trial a new brain implant last October, with phenomenal results – his daytime seizures were reduced by 80%.
“It’s had a huge impact on his life and has prevented him from having the falls and injuring himself that he was having before,” says Martin Tisdall, a consultant paediatric neurosurgeon at Great Ormond Street Hospital (Gosh) in London, who implanted the device. “His mother was talking about how he’s had such a improvement in his quality of life, but also in his cognition: he’s more alert and more engaged.”
About Author
More Stories
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
Cancer experts warn of coffee enemas and juice diets amid rise in misinformation
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip